LabCompass

Don B. Sanders

Medicine · Indiana University

OpenAlex ORCID
Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchTracheal and airway disordersDelphi Technique in Research

Publications

181

Citations

3,973

Est. group size

~1

Recurring co-author estimate

Active years

50

Publishing since 1976

Research summary
AI-generated

Don B. Sanders conducts clinical research on cystic fibrosis, a genetic condition that affects the lungs and other organs. The work focuses on how to measure and treat lung decline, including studies of pulmonary flare-ups (exacerbations), antibiotic use, lung function testing at home, the airway microbiome (the community of microbes in the lungs), and newer gene-targeted drug therapies.

Cystic fibrosis pulmonary exacerbationsLung function measurement and home spirometryAntibiotic treatment and airway microbiomeCFTR-modulator drug therapiesExhaled breath and biomarker analysis

Publication activity has been steady over the past decade, averaging around 11 papers per year in the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 10.6/year recently
2017: 13 publications172018: 8 publications182019: 5 publications192020: 16 publications202021: 17 publications212022: 12 publications222023: 18 publications18232024: 12 publications242025: 11 publications2526
Recent publications
Publishes in
  • Journal of Cystic Fibrosis×47
  • Pediatric Pulmonology×11
  • Annals of the American Thoracic Society×6
  • American Journal of Respiratory and Critical Care Medicine×5
  • PMC×5

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile